GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FEED · Dec 31, 2024

ENvue Medical, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001641172-25-001613General Corporate
Capex intensity56thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.12% · OPTIONAL · VALID

Operating cash generation78thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-98.36% · OPTIONAL · VALID

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

12.05% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure0thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

85.65% · OPTIONAL · VALID

Gross margin33thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.gross_margin

58.95% · CORE · VALID

Operating margin78thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.operating_margin

-140.03% · CORE · VALID

R&D intensity67thOwn-history percentile · N=9
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

35.54% · OPTIONAL · VALID

SBC intensity44thOwn-history percentile · N=9
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

13.92% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History16 statesHistory building
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.00%
Current
0.12%
Delta
0.12%
Cash Generation Increased
Previous
-222.34%
Current
-98.36%
Delta
123.98%
Growth Increased
Previous
-17.90%
Current
12.05%
Delta
29.95%
Inventory Pressure Decreased
Previous
598.40%
Current
85.65%
Delta
-512.75%
Margin Increased
Previous
35.37%
Current
58.95%
Delta
23.58%
Profitability Increased
Previous
-257.98%
Current
-140.03%
Delta
117.95%
R And D Intensity Decreased
Previous
66.22%
Current
35.54%
Delta
-30.69%
Sbc Intensity Decreased
Previous
15.43%
Current
13.92%
Delta
-1.51%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.